2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
23
Thoracic
14
Breast
12
Genitourinary
9
CNS
9
Tumor-Agnostic
6
Gynecologic
4
Other hematologic neoplasm
3
Lymphoid
3
Endocrine
3
Head & Neck
2
Dermatologic
2
Other neoplasm
1
Other
1
Conditions
Stomach Ulcer
1
Stomach Neoplasms
1
Overweight
1
Obesity
1
Interventions
Exercise
28
Metformin
24
Surveys and Questionnaires
19
Radiotherapy
14
Methods
14
Early Intervention, Educational
13
Counseling
13
Educational Status
12
naloxegol
10
Standard of Care
10
Tirzepatide
9
Nutrition Assessment
9
Diet Therapy
9
Cisplatin
9
Resistance Training
8
Psychiatric Rehabilitation
8
Diet
8
Therapeutics
7
Interviews as Topic
7
alvimopan
6
Liraglutide
6
Fibroblast Growth Factor 7
6
Caloric Restriction
6
semaglutide
5
Radiation
5
Low-Level Light Therapy
5
Injections
5
Exenatide
5
Diet, Mediterranean
5
Dexamethasone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Propofol
×
Other
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled